1. S. Abel, E. Van der Ryst, G.J. Muihead, A. Rosario, A. Edgington, G. Weissgerber, Pharmacokinetics of single and multiple oral doses of UK-427,857-A novel CCR5 antagonist in healthy volunteers, in: 10th Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2003
2. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1;Alkhatib;Science,1996
3. The discovery of tropane-derived CCR5 receptor antagonists;Armour;Chem. Biol. Drug. Des.,2006
4. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity;Baba;Proc. Natl. Acad. Sci. USA,1999
5. TAK-652 inhibits CCR5-mediated human immunodeficiency virus type 1 infection in vitro and has favorable pharmacokinetics in humans;Baba;Antimicrob. Agents Chemother.,2005